Back to Stakeholders

Specialized Academic Departments and Institutes Independent Academic Research Groups

University of Alabama at Birmingham

United States

6 Trials

Major research university and academic medical center in Birmingham, Alabama. A key site in the first federally funded psilocybin trial in 50 years — a NIH/NIDA-funded multisite study on psilocybin for smoking cessation led by Dr. Peter Hendricks, alongside Johns Hopkins and NYU.

Quick Facts

Type: Other
HQ: United States
Website: Visit

Sponsored Trials

5

Exploratory Study of Low Dose Psilocybin

Start Date: March 1, 2022
Compounds: Placebo, Psilocybin

Psilocybin-facilitated Treatment for Chronic Pain

Start Date: January 1, 2022
Compounds: Psilocybin, Placebo

Psilocybin-facilitated Treatment for Cocaine Use

Start Date: May 1, 2015
Compounds: Psilocybin, Placebo

miRNAs, Suicide, and Ketamine – Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome

Start Date: April 20, 2015
Compounds: Ketamine

Treatment of Suicidal Ideation With Intravenous Ketamine Infusion

Start Date: May 1, 2012
Compounds: Ketamine, Placebo

Collaborated Trials

1

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

Start Date: August 1, 2022
Compounds: Psilocybin, Placebo